Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Renata Budzynska"'
Autor:
Katarzyna Majzner, Magdalena Jarosz, Nikola Mielniczek, Ewelina Bik, Malgorzata Baranska, Joanna Denbigh, Renata Budzynska
Publikováno v:
The Analyst. 144:6561-6569
This paper describes how tunicamycin (Tu), the most widely used pharmacological agent for inducing endoplasmic reticulum (ER) stress, interacts with endothelial cells. Our results show that tunicamycin enters the cells and accumulates within the ER a
Sepsis caused by Chromobacterium violaceum – probably the first case in Europe, or Macbeth read anew
Autor:
Renata Budzynska-Nosal, Krzysztof Marczewski, Anna Jędruszczak, Marek Maciejewski, Marta Węgrzyn-Bąk
Publikováno v:
Annals of Agricultural and Environmental Medicine. 26:508-510
Rare diseases, almost by definition, present us with diagnostic as well as therapeutic difficulties as. They also include infectious diseases outside endemic areas. Without expecting them, we are not preparing to fight them. Like Macbeth, we feel saf
Autor:
Krzysztof Marczewski, Renata Budzynska-Nosal, Marta Wegrzyn-Bek, Krzysztof Gutkowski, Janusz Strzelczyk, Beata Kos-Kudła
Publikováno v:
Endocrine Abstracts.
Autor:
Michal Slomian, Renata Budzynska-Nosal, Marek Maciejewski, Krzysztof Marczewski, Agnieszka Sawicka, Malgorzata Gasiorek
Publikováno v:
Endocrine Abstracts.
Autor:
Marek Maciejewski, Krzysztof Marczewski, Michal Slomian, Agnieszka Sawicka, Renata Budzynska-Nosal, Beata Kozlowska
Publikováno v:
Endocrine Abstracts.
Autor:
Marek Maciejewski, Krzysztof Marczewski, Michal Slomian, Agnieszka Sawicka, Renata Budzynska-Nosal, Beata Kozlowska
Publikováno v:
Endocrine Abstracts.
Autor:
Urszula Kanska, Adam Opolski, Monika Jagiello, Janusz Boratyński, Renata Budzynska, Joanna Wietrzyk, Dmitry Nevozhay
Publikováno v:
Oncology research. 16(9)
Conjugation of anticancer drugs with different carriers has been extensively studied recently as a potential method of obtaining improved drug forms. The conjugation often results in the increase of the therapeutic effect, alteration of a toxicity pr
Publikováno v:
Biotechnology and applied biochemistry. 49(Pt 1)
In the present paper, we describe a procedure for the preparation of mannan-protein conjugates. Mannan from Saccharomyces cerevisiae (baker's yeast) was oxidized by NaIO4 and coupled with BSA by means of high-temperature glycation. Depending on the t
Autor:
Dmitry, Nevozhay, Renata, Budzynska, Monika, Jagiello, Urszula, Kanska, Mohamed Salah, Omar, Adam, Opolski, Joanna, Wietrzyk, Janusz, Boratynski
Publikováno v:
Anticancer research. 26(3A)
Methotrexate (MTX) is widely used in the treatment of a number of oncological and hematological diseases. Due to its known limitations, MTX is often conjugated with different carriers to obtain amended forms of the drug. In this study, the potential
Autor:
Dmitry, Nevozhay, Renata, Budzynska, Urszula, Kanska, Monika, Jagiello, Mohamed Salah, Omar, Janusz, Boratynski, Adam, Opolski
Publikováno v:
Anticancer research. 26(2A)
Methotrexate (MTX) is widely utilized in the clinical treatment of many forms of cancer. However, the drug has a short plasma half-life and causes toxic effects on normal proliferating cells. Conjugation with carriers is a possible way to alter these